[Treatment of sequelae of burns on the trunk]. / Die Behandlung von Spätfolgen nach Verbrennungen im Bereichedes Rumpfes]

The management of burn scars of the trunk is discussed, in respect of the specific problems related to different areas such as the axilla, thorax and back, the female breast and the perineum as well as the external genitalia. Special emphasis is placed on the different aspects of burn sequelae of the female breast with regard to pre- and postpuberty age. The prevention and therapy of the burn scar carcinoma are dealt with.

[Selective neurectomies in hemifacial spasm: an anatomo-pathologic discovery]. / Neurectomies sélectives pour spasme hémifacial: une découverte anatomo-pathologique.

Today the treatment of choice in hemifacial palsy is selective neurectomy of the branches of the facial nerve. Palliative surgery has improved experience in the treatment of facial palsy. An anatomical finding is reported which could contribute to a better understanding of the etiology of facial spasm.

[Surgical treatment of malignant skin epitheliomas. Principles, methods, results]. / Operative Behandlung maligner Epitheliome der Haut. Grundsätze, Methoden, Ergebnisse

From personal experience in the treatment of 655 patients with malignant epitheliomas of the skin, treated from 1966 to 1973 at the Department of Plastic and Reconstructive Surgery at the University Hospital, Innsbruck, the basic principles, methods, and results of treatment are reported. An adequate resection and a primary reconstruction is the method of choice. The clinical data and follow-up observations are analyzed and special types of treatment and indications are discussed. With it the 5-year-cure-rate of basal-cell carcinomas was 92%, of squamous-cell carcinomas 83%.

Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).

The usefulness and limitations of the carcinoembryonic antigen (C.E.A.) radioimmunoassay for the evaluation of tumour resection and for the detection of tumour relapse were studied in patients with large-bowel carcinoma. The level of plasma-C.E.A. was determined before any treatment in a group of 101 patients with histologically proven adenocarcinoma of the colon and rectum. 71% of all patients and 63% of cases with localised tumour (Dukes A and B) had a preoperative C.E.A. value of 5 ng. per ml. or higher. This limit was reached by only 1 of 90 apparently healthy, non-smoking blood-donors. Among 45 patients for whom a complete tumour resection was reported, all patients except 5 showed a drop of C.E.A. to normal values after surgery. The 5 patients whose C.E.A. did not fall to below 5 ng. per ml. showed a subsequent rise in C.E.A. level and were all found later to have a tumour relapse. The results indicate that an incomplete drop of circulating C.E.A. level one month after surgery has a bad prognostic significance. 22 of these patients were followed up by repeated C.E.A. radioimmunoassay for several months after surgery. 8 showed a progressive increase in C.E.A. levels preceding clinical diagnosis of tumour relapse by two to ten months. 6 other patients showed a moderate increase in C.E.A. levels, suggesting a tumour relapse not yet clinically detectable. The remaining 8 patients showed no increase in C.E.A. level above 5 ng. per ml. and no clinical symptoms of relapse. The results demonstrate that relapses of colon and rectum carcinoma can be detected by increased C.E.A. levels months before the appearance of any clinical evidence.